4th Quarter - Report

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

Firm
Client
Income
—
Expenses
$810,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Medicare Part D redesign, rebate reform and international pricing index (including H.R. 3, H.R. 19) Medicaid Drug Rebate Program (MDRP), including value-based purchasing (VBP) arrangements and line extensions Issues related to Biosimilars

LobbyistCovered position, as disclosed
KATHARINE TROLLER BOND —
JULIAN MALASI —
SARAH ELIZABETH NORDSTROM —
MARY BRIDGET WALSH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (117th), H.R. 19 (117th)

Animals ANI

Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to Rural Broadband Issues related to One Health Issues related to Pesticide Registration Improvement Act and issues related to compounding

LobbyistCovered position, as disclosed
SCOTT BENNETT —
BILL DAVIS —
MARY BRIDGET WALSH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Agriculture, Dept of (USDA); Environmental Protection Agency (EPA)

Trade (domestic/foreign) TRD

Prescription drug manufacturing and supply chains

LobbyistCovered position, as disclosed
KATHARINE TROLLER BOND —
BILL DAVIS —
JULIAN MALASI —
SARAH ELIZABETH NORDSTROM —
MARY BRIDGET WALSH —

Contacted: SENATE; Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Issues related to FY 2022 Appropriations S. 2599, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022

LobbyistCovered position, as disclosed
SCOTT BENNETT —
KATHARINE TROLLER BOND —
BILL DAVIS —
JULIAN MALASI —
SARAH ELIZABETH NORDSTROM —
MARY BRIDGET WALSH —

Contacted: Agriculture, Dept of (USDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2599 (117th)

Defense DEF

Issues Related to National Defense Authorization Act

LobbyistCovered position, as disclosed
SCOTT BENNETT —
BILL DAVIS —
MARY BRIDGET WALSH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to prescription drug pricing and value Issues related to ICD-10 diagnosis codes Prescription drug manufacturing and supply chains Issues regarding the ongoing COVID-19 public health emergency Issues related to Biosimilars (including H.R. 7047) Issues related to the 340B program Issues related to tax Issues related to reauthorizing the Prescription Drug and Biosimilar User Fee Agreements Issues related to Intellectual Property Issues related to Inflation Reduction Act

LobbyistCovered position, as disclosed
KATHARINE TROLLER BOND —
JULIAN MALASI —
SARAH ELIZABETH NORDSTROM —
MARY BRIDGET WALSH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7047 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.